These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 19501422

  • 1. Functional dissection of an IFN-alpha/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection.
    Zhou J, Huang JD, Poon VK, Chen DQ, Chan CC, Ng F, Guan XY, Watt RM, Lu L, Yuen KY, Zheng BJ.
    J Hepatol; 2009 Aug; 51(2):322-32. PubMed ID: 19501422
    [Abstract] [Full Text] [Related]

  • 2. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection.
    Zhou J, Smith DK, Lu L, Poon VK, Ng F, Chen DQ, Huang JD, Yuen KY, Cao KY, Zheng BJ.
    J Viral Hepat; 2009 Jan; 16(1):45-52. PubMed ID: 18761606
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection.
    Zhou J, Lu L, Yuen MF, Lam TW, Chung CP, Lam CL, Zhang B, Wang S, Chen Y, Wu SH, Poon VK, Ng F, Chan CC, Jiang S, Yuen KY, Zheng BJ.
    J Hepatol; 2007 Feb; 46(2):198-205. PubMed ID: 17125879
    [Abstract] [Full Text] [Related]

  • 4. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
    Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C.
    Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
    [Abstract] [Full Text] [Related]

  • 5. The -928 G/C and -362 G/C single-nucleotide polymorphisms in the promoter of MCP-1: Increased transcriptional activity and novel binding sites.
    Nyquist P, Zhang J, De Graba TJ.
    Cerebrovasc Dis; 2010 Feb; 29(3):242-7. PubMed ID: 20029197
    [Abstract] [Full Text] [Related]

  • 6. Association between the IFNA1 (-2Cx2192;T) Polymorphism and Increased IFNAR1 Gene Expression Levels in Chronic Hepatitis B Infection.
    Santos JC, de Deus DM, de Moura IM, Lopes EP, Alves MR, Coêlho MR.
    Intervirology; 2015 Feb; 58(6):393-402. PubMed ID: 27101083
    [Abstract] [Full Text] [Related]

  • 7. Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.
    Pottier N, Cheok MH, Yang W, Assem M, Tracey L, Obenauer JC, Panetta JC, Relling MV, Evans WE.
    Hum Mol Genet; 2007 Oct 01; 16(19):2261-71. PubMed ID: 17616514
    [Abstract] [Full Text] [Related]

  • 8. Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Karamitros T, Papatheodoridis G, Paraskevis D, Hatzakis A, Mbisa JL, Georgopoulou U, Klenerman P, Magiorkinis G.
    Front Immunol; 2018 Oct 01; 9():777. PubMed ID: 29713327
    [Abstract] [Full Text] [Related]

  • 9. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort.
    Diop G, Hirtzig T, Do H, Coulonges C, Vasilescu A, Labib T, Spadoni JL, Therwath A, Lathrop M, Matsuda F, Zagury JF.
    Biomed Pharmacother; 2006 Nov 01; 60(9):569-77. PubMed ID: 17027223
    [Abstract] [Full Text] [Related]

  • 10. PARP-1 expression in the mouse is controlled by an autoregulatory loop: PARP-1 binding to an upstream S/MAR element and to a novel recognition motif in its promoter suppresses transcription.
    Vidaković M, Gluch A, Qiao J, Oumard A, Frisch M, Poznanović G, Bode J.
    J Mol Biol; 2009 May 15; 388(4):730-50. PubMed ID: 19303024
    [Abstract] [Full Text] [Related]

  • 11. Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection.
    Zhang G, Li Z, Han Q, Li N, Zhu Q, Li F, Lv Y, Chen J, Lou S, Liu Z.
    Infect Genet Evol; 2011 Oct 15; 11(7):1624-30. PubMed ID: 21712100
    [Abstract] [Full Text] [Related]

  • 12. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R, Chandra PK, Aboulnasr F, Panigrahi R, Ferraris P, Aydin Y, Reiss K, Wu T, Balart LA, Dash S.
    PLoS One; 2015 Oct 15; 10(5):e0125962. PubMed ID: 25961570
    [Abstract] [Full Text] [Related]

  • 13. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.
    J Gastroenterol Hepatol; 2006 Jul 15; 21(7):1163-9. PubMed ID: 16824070
    [Abstract] [Full Text] [Related]

  • 14. A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection.
    Zhou J, Chen DQ, Poon VK, Zeng Y, Ng F, Lu L, Huang JD, Yuen KY, Zheng BJ.
    Immunogenetics; 2009 Jun 15; 61(6):423-30. PubMed ID: 19488747
    [Abstract] [Full Text] [Related]

  • 15. Association of the IFNAR1-17470 and IL-10-592 cytokine variants with susceptibility to chronic hepatitis B viral infections in a Chinese population.
    Xiang Y, Huang SF, Xia JR, Ye DQ, Chen P, Yang SS, Sun S, Lai XF, Zhang LP.
    Genet Mol Res; 2014 Nov 07; 13(4):9187-95. PubMed ID: 25501140
    [Abstract] [Full Text] [Related]

  • 16. A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection.
    Zou R, Zhang G, Li S, Wang W, Yuan J, Li J, Wang Y, Lin Y, Deng Y, Zhou B, Gao GF, Liu Y.
    Sci Rep; 2015 Dec 18; 5():18541. PubMed ID: 26679744
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.
    Cho IR, Oh M, Koh SS, Malilas W, Srisuttee R, Jhun BH, Pellegrini S, Fuchs SY, Chung YH.
    Int J Mol Med; 2012 Apr 18; 29(4):581-6. PubMed ID: 22218495
    [Abstract] [Full Text] [Related]

  • 18. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.
    Beranger GE, Momier D, Rochet N, Quincey D, Guigonis JM, Samson M, Carle GF, Scimeca JC.
    J Bone Miner Res; 2006 Nov 18; 21(11):1757-69. PubMed ID: 17002555
    [Abstract] [Full Text] [Related]

  • 19. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O, Kowalak JA, Smulson ME, Nussbaum RL.
    Am J Hum Genet; 2005 Mar 18; 76(3):478-92. PubMed ID: 15672325
    [Abstract] [Full Text] [Related]

  • 20. Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection.
    Song le H, Xuan NT, Toan NL, Binh VQ, Boldt AB, Kremsner PG, Kun JF.
    Eur Cytokine Netw; 2008 Dec 18; 19(4):204-10. PubMed ID: 19103527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.